A trusted, quality partner for manufacturers to painlessly launch their precious products in new geographies. Blackrock Pharmaceuticals Limited is a rapidly expanding, privately owned company focused of the development and marketing of cost competitive niche generic medicines, and consumer healthcare products, across the UK and Europe.
The company’s growth is based on the strategic selection of our own development products and markets supported with in-licensing and product acquisition opportunities. We have presence in multiple EU and international markets and are aiming to rapidly expand our coverage in the coming years. Our experienced, dedicated and highly professional team offer quality focused expertise covering all EU regulatory licensing activities; EU QP release and Sales and Marketing activities.
Our product development pipeline of over 20 pharmaceutical products in various stages of development and registration, covers many therapeutic disease areas including: Antispasmodics; Antidepressants; Antithyroid; Rheumatic disease; Bowel disease and Diabetes.
If you are a manufacturer interested in partnering with Blackrock Pharma, please contact Stephen Loughrey on 028 90151051 or +447813 216727 or email Stephen.firstname.lastname@example.org Specialties: Generic Pharmaceuticals, Regulatory and Quality core, Product approval and launch, Joint Ventures & distribution agreements, Strategic portfolio planning, Sales and marketing, Driving high profit margin